Core Viewpoint - The company Beike (688793.SH) is under investigation by the China Securities Regulatory Commission (CSRC) for market manipulation, involving its actual controller and chairman, Ma Xuejun, who has been investigated twice in a short period for various financial misconducts [1][2]. Group 1: Company Background - Beike was established in 2001 and went public on the Sci-Tech Innovation Board in July 2021, focusing on the design, research, development, production, sales, and service of smart portable health hardware, including products like neck and eye massagers [1]. - Ma Xuejun has been the main operator since the company's inception, holding a direct stake of 37.51% and controlling a total of 49.38% of the shares, giving him absolute control over the company [1]. Group 2: Financial Misconduct - Ma Xuejun has been involved in various financial misconducts, including the misappropriation of company funds totaling 16.69 million yuan through employee loans, transferring 54 million yuan via related companies, and prepaying suppliers, with a total of 85.93 million yuan misappropriated in 2024 alone [2]. - The company has also failed to disclose 30 million yuan in illegal guarantees, raising further concerns about its governance [2]. Group 3: Financial Performance - In 2024, Beike reported revenues of 1.085 billion yuan and a net profit of only 10.25 million yuan. By the third quarter of 2025, the company's total assets were 676 million yuan, liabilities were 398 million yuan, and shareholders' equity was reduced to 278 million yuan, with a negative cash flow from operating activities of 28.1 million yuan [3]. - As of February 6, 2026, the company's stock price was 22.71 yuan per share, reflecting a decline of approximately 81.5% from its peak market value, with a total market capitalization of 1.952 billion yuan [3]. Group 4: Regulatory Response - The company stated that the investigation pertains to Ma Xuejun personally and is not expected to significantly impact its daily operations, with Ma continuing to fulfill his duties and the company pledging to cooperate with the regulatory investigation [3].

Core Viewpoint - The company, Beiliang, is under investigation by the China Securities Regulatory Commission (CSRC) for alleged market manipulation involving its actual controller, Ma Xuejun, which may impact investor confidence and future operations [1][5]. Group 1: Investigation Details - On February 4, the CSRC issued a notice to Ma Xuejun regarding the investigation for suspected market manipulation [1]. - This investigation is separate from a previous case in December 2022, where both the company and Ma Xuejun were investigated for information disclosure violations [5]. Group 2: Company Operations - Beiliang stated that the investigation pertains to Ma Xuejun personally and will not significantly affect the company's daily operations, with him continuing to fulfill his duties [3][4]. - The company is committed to complying with legal and regulatory requirements and will keep stakeholders informed about the investigation's progress [4]. Group 3: Financial Performance - Beiliang is a high-tech enterprise focused on the innovation and development of health products, primarily engaged in the design, research, production, sales, and service of smart portable health hardware [7]. - The latest earnings forecast indicates that the company expects to report a net loss of between 84 million to 105 million yuan for 2025, marking a shift from profit to loss [7]. - As of February 5, Beiliang's stock closed at 22.97 yuan per share, reflecting a 0.75% increase, with a total market capitalization of 1.974 billion yuan [7].

Core Viewpoint - *ST HuKe's stock price increased by 11.7% to 4.01 yuan, with a total market value of 1.319 billion yuan, ranking 13th in the trade sector and 5175th in the A-share market [1] Performance Disclosure Highlights - The company expects 2025 annual operating revenue to be between 7.5 million and 11 million yuan, with the same range for net profit attributable to shareholders estimated between 3.9 million and 5.8 million yuan [1][3] - The net profit after deducting non-recurring items is projected to be between 280,000 and 420,000 yuan [1] Company Announcement Summary - The company received a notice from the China Securities Regulatory Commission regarding an investigation for suspected violations of information disclosure laws [1][3] - If the net profit for 2025 is negative and revenue is below 300 million yuan, the company's stock will be delisted [1][3] - The former controlling shareholder's fund occupation balance is 348.61 million yuan, accounting for 921.63% of the latest audited net assets [1][3] - The company has made a provision for bad debts of 89.9% on prepaid petrochemical payments, indicating further impairment risks [1]

Core Viewpoint - The company Beiqing Song (688793.SH), known as the "first stock of smart health hardware," has reported a significant turnaround in its 2025 annual performance forecast, projecting a net loss of 84 million to 105 million yuan, a decline of over 900% compared to a slight profit in 2024, amid high marketing costs and an investigation into information disclosure violations involving its actual controller [1][2][5]. Financial Performance - The 2025 performance forecast indicates a net loss of 84 million to 105 million yuan, with a non-recurring net profit loss of 71 million to 92 million yuan, contrasting sharply with a net profit of 10.25 million yuan in 2024, marking a year-on-year decline of over 900% [2][4]. - In the fourth quarter of 2025, the projected net loss is between 18.27 million and 39.37 million yuan, significantly higher than the 284,660 yuan loss in the fourth quarter of 2024, indicating a worsening trend [2][4]. - For the first three quarters of 2025, the company reported approximately 552 million yuan in revenue, a substantial decrease of 34.07%, with a net profit loss of 65.63 million yuan, a year-on-year decline of 600.98% [4][5]. Marketing and Cost Structure - Marketing expenses remain high, accounting for nearly 60% of revenue, which has not effectively driven revenue growth and has instead compressed profit margins, contributing to the company's poor performance [6][7]. - In the first three quarters of 2025, the company spent approximately 316 million yuan on sales expenses, a reduction of 27.52% year-on-year, but this decline was insufficient compared to the 34.07% drop in revenue [6]. - The proportion of sales expenses to revenue was 57.32% in the first three quarters of 2025, indicating that for every 100 yuan of revenue, nearly 60 yuan was spent on sales, significantly higher than the industry average [6][7]. Governance and Regulatory Issues - The actual controller, Ma Xuejun, is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure, which has exposed internal control issues within the company [8][10]. - Ma Xuejun has been involved in long-term fund occupation issues, with a total of 12.08 million yuan occupied through various means, although the principal has been repaid [10][11]. - The company has received multiple regulatory inquiries and warnings due to internal control vulnerabilities and issues related to information disclosure accuracy [11].

2026年1月29日，ST新华锦（维权）（sh600735）触及跌停，跌停价6.09元，涨幅-4.99%，总市值26.11 亿元，流通市值25.91亿元，截止发稿，总成交额1.84亿元。 根据喜娜AI异动分析，ST新华锦跌停原因可能如下，资金占用+业绩亏损+控股股东问题： 1、公司经 营存在重大隐患：公司面临4.06亿元资金占用问题，触及退市红线，若1个月内未解决将导致ST警示， 这严重影响公司资金流动与业务开展。且控股股东99.64%质押接近满仓，存在平仓风险，99.97%股份 被冻结/标记，这些都反映出公司内部治理和资金状况不佳。 2、业绩表现不佳：2024年净利润下降 354.59%，2025年上半年续降39.45%，2025年资金流向仍处于亏损状态，归母净利润为 - 1.42亿~ - 9500 万，盈利压力大，对股价形成压制。 3、控股股东问题冲击信心：2026年1月21日公司收到关于控股股 东破产重整相关事项的监管工作函，暴露出控股股东层面问题，影响公司治理和未来规划，冲击市场信 心。 4、资金流向及短期表现：2026年1月23日入选龙虎榜，虽难以判断资金是长期关注还是短期炒 作，但结合公司诸多利空 ...

新华锦公告称，截至2025年半年度报告披露日，新华锦集团及其关联方非经营性占用公司资金4.06亿 元，需在收到《行政监管措施决定书》6个月内归还。截至公告披露日，资金占用解决方案未确定，新 华锦集团等已被裁定受理破产重整，占用资金存在无法全额清偿风险。若未在规定时间清收资金，公司 股票将依次面临停牌、被实施退市风险警示、终止上市交易。公司生产经营正常，将及时披露进展。 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我 一、涉信息披露违法违规 2025年12月12日，上海宽频科技股份有限公司（证券简称：*ST沪科（维权））收到中国证监会下发的 《立案告知书》。 至于违规细节，公告中并未披露，具体还需等待监管调查。上海沪紫律师事务所刘鹏律师表示，暂 定于2025年12月12日（含当日）之前买入，并在2025年12月13日之后卖出或仍持有而亏损的即可参与维 权，挽回损失。（*ST沪科维权入口） 二、超3亿资金占用顽疾难除 梳理公司过往公告发现，截至2025年10月底，*ST沪科原控股股东南京斯威特集团有限公司及其关联方 违规占用上市公司资金余额高达3.49亿元，占公司最近一期经审计净资产的921.63%。公司虽已通过诉 讼、司法执行等方式追偿，但由于原控股股东南京斯威特集团生产经营基本停止，资产已被轮候查封冻 结，法院未能查找到可供执行的财产，追偿工作陷入停滞。 这一巨额 ...

Core Viewpoint - *ST Aowei is facing significant financial distress, with its stock price hitting a record low and potential delisting risks due to market capitalization falling below 5 billion yuan and share price below 1 yuan [1][4]. Financial Performance - In 2024, the company reported a revenue of 291 million yuan, with a net profit loss of 50 million to 75 million yuan, significantly lower than the previously forecasted revenue of 450 million to 520 million yuan [5][4]. - For the first three quarters of 2025, the company experienced a staggering 87.01% year-on-year decline in revenue, with a net profit loss of 188 million yuan, marking a 988% drop compared to the previous year [8]. Stock Market Situation - As of January 19, 2026, *ST Aowei's stock price was at 0.89 yuan per share, having hit the daily limit down for four consecutive trading days, indicating severe market distress [1]. - The company has been under a delisting risk warning since April 2025, with its stock trading under the "*ST" designation due to financial irregularities [3][4]. Operational Challenges - The company's key metal processing business has been halted due to supplier debt disputes and the occupation of funds by its second-largest shareholder, Shanghai Donghexin, leading to operational disruptions [6][7]. - As of the end of 2024, approximately 208 million yuan of funds were occupied, with only 60.045 million yuan repaid by the second-largest shareholder, leaving a significant outstanding balance of 189 million yuan [7]. Regulatory Issues - The company has faced regulatory scrutiny from the Liaoning Securities Regulatory Bureau due to inaccuracies in financial disclosures and performance forecasts, resulting in administrative penalties [4][5].

Group 1 - The company, Haide Co., has been investigated by the China Securities Regulatory Commission (CSRC) for information disclosure violations related to the misuse of funds by its controlling shareholder and related parties, amounting to 884.32 million yuan [1][3][4] - As of April 24, 2025, the company stated that the misappropriated funds and corresponding interest of 52.88 million yuan have been fully returned and accounted for according to accounting standards [1][3] - The CSRC's investigation was officially announced on November 28, 2025, indicating serious regulatory scrutiny and potential penalties for the company and its actual controller [1][3] Group 2 - The misappropriation of funds dates back to April 21, 2021, when the company began its acquisition and restructuring of non-performing assets, during which time the controlling shareholder's related parties borrowed funds from the debt trading parties [2][4] - The total amount of funds misappropriated is significant enough to raise concerns among investors, with the company acknowledging the issue in its public announcements [2][4] - Investors who purchased shares between April 21, 2021, and April 28, 2025, or before November 28, 2025, and sold or held them at a loss after these dates are eligible to participate in compensation claims [1][3]

Core Viewpoint - New Thinking Motor Co., Ltd. has submitted an IPO application to the Hong Kong Stock Exchange, with concerns regarding the independence of its underwriters and potential conflicts of interest due to its ties with major clients and suppliers [1][2]. Group 1: Company Overview - New Thinking Motor, established in 2014, is a leading manufacturer of micro precision motors, particularly known for its development of the first mobile phone voice coil motor in 1994 [1]. - The company has undergone multiple rounds of financing from December 2018 to January 2023, raising a total of 655 million yuan, with a post-investment valuation of 2.4 billion yuan [2]. Group 2: Shareholding and Management - The actual controller of New Thinking is Cai Rongjun, who holds a combined 56.97% stake through direct and indirect ownership [2]. - The board consists of seven members, including Cai Rongjun as the non-executive chairman and Cai Zhenpeng as the executive vice chairman and CEO [3]. Group 3: Equity Incentive Plans - New Thinking has implemented three equity incentive plans since December 2020, granting a total of 3.8225 million shares at a fixed price of 3.93 yuan per share, significantly lower than historical financing prices [3]. - The pricing of these equity incentives is only 41.5% of the lowest historical price and 17.49% of the highest, raising concerns about potential benefit transfers [3]. Group 4: Financial Performance - In 2023, 2024, and the first three quarters of 2025, New Thinking reported revenues of 855 million yuan, 1.565 billion yuan, and 1.457 billion yuan, respectively, with net profits of -30 million yuan, 105 million yuan, and 97 million yuan [6]. - The company's gross margin has declined from 16.4% to 16.1% during the same period, with specific product lines experiencing significant margin drops [6]. Group 5: Customer Concentration and Risks - New Thinking's revenue is highly concentrated, with the top five customers accounting for over 88% of total revenue, leading to potential pricing and negotiation disadvantages [7]. - The company has a significant reliance on Oufei Light, which has been its largest customer, contributing 37.9% to 29.1% of total revenue across the reported years [7]. Group 6: Accounts Receivable and Financial Concerns - New Thinking's accounts receivable have increased by 137.89% over the reporting periods, with days sales outstanding exceeding 127 days, indicating potential liquidity issues [8][9]. - The accounts receivable from Oufei Light have also seen substantial growth, raising concerns about financial support to shareholders and related parties through operational funding [9].